Ligand (LGND) Down 4.9% Since Last Earnings Report: Can It Rebound?
nasdaq.com
news
2022-06-03 11:31:00

It has been about a month since the last earnings report for Ligand Pharmaceuticals (LGND). Shares have lost about 4.9% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Ligand due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.

Ligand Beats Q1 Earnings & Sales Estimates

Ligand reported first-quarter 2022 adjusted earnings of 76 cents per share, beating the Zacks Consensus Estimate of 61 cents.
